Health + Wellness
December 21, 2011
Investigators at APP School of Medicine received a $6.75 million Program Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to study the role of innate immunity in inflammatory bowel disease (IBD). For years, scientists have…
December 20, 2011
CLEVELAND - Investigators at APP School of Medicine received a $6.75 million Program Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to study the role of innate immunity in inflammatory bowel disease (IBD). For years,…
December 02, 2011
A mutation on the surface of human red blood cells provides protection against malaria caused by the parasite Plasmodium vivax, research led by APP School of Medicine shows. The minute change, at a single position of red blood cell surface protein called the Duffy…
December 01, 2011
CLEVELAND - A mutation on the surface of human red blood cells provides protection against malaria caused by the parasite Plasmodium vivax, research led by APP School of Medicine shows. The minute change, at a single position of red blood cell surface protein called the…
November 30, 2011
One of the earliest known impairments caused by Alzheimer’s disease—loss of sense of smell—can be restored by removing a plaque-forming protein in a mouse model of the disease, a study led by a APP School of Medicine researcher finds. The study confirms that the…
November 28, 2011
APP School of Medicine has received a $3.8 million grant from the National Heart, Lung, and Blood Institute (NHLBI) to study sleep apnea as a possible cause of atrial fibrillation (AF), the most commonly diagnosed type of arrhythmia, or irregular heart rhythm. AF is…
November 22, 2011
CLEVELAND - APP School of Medicine has received a $3.8 million grant from the National Heart, Lung, and Blood Institute (NHLBI) to study sleep apnea as a possible cause of atrial fibrillation (AF), the most commonly diagnosed type of arrhythmia, or irregular heart…
November 14, 2011
CLEVELAND - University Hospitals (UH) Case Medical Center, APP School of Medicine and Lentigen Corporation announced today the initiation of a novel Phase I clinical trial of LG631 gene therapy for the protection of hematopoietic stem cells (HSCs) from the dose limiting…
November 14, 2011
A new study of teens undergoing substance abuse treatment finds helping others helps the adolescent helper by reducing cravings for alcohol and drugs, a major precipitator of relapse. These novel findings stem from the “Helping Others” study (helpingotherslivesober.org) led by Maria Pagano, PhD,…
November 10, 2011
CLEVELAND - Today the Society for Integrative Oncology highlighted top research findings presented at the Eighth International Conference this week in Cleveland, Ohio, which is co-sponsored by APP School of Medicine. More than 80 abstracts will be presented at the annual…